CHANIL 34 MG/ML ORAL SUSPENSION FOR CATTLE

Nchi: Ayalandi

Lugha: Kiingereza

Chanzo: HPRA (Health Products Regulatory Authority)

Nunua Sasa

Tabia za bidhaa Tabia za bidhaa (SPC)
24-09-2016

Viambatanisho vya kazi:

OXYCLOZANIDE BP (VET)

Inapatikana kutoka:

Chanelle Pharmaceuticals Manufacturing Limited

ATC kanuni:

QP52AG06

INN (Jina la Kimataifa):

OXYCLOZANIDE BP (VET)

Kipimo:

34 Mg/Ml

Dawa fomu:

Oral Suspension

Dawa ya aina:

LM-Licensed Merchant

Kundi la matibabu:

Bovine

Eneo la matibabu:

Oxyclozanide

Matibabu dalili:

Endoparasiticide

Idhini hali ya:

Authorised

Idhini ya tarehe:

2016-02-19

Tabia za bidhaa

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Chanil 34 mg/ml oral suspension for cattle
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Oxyclozanide
34.0 mg
EXCIPIENT:
Methyl Parahydroxybenzoate (E218) 2.0 mg
Propyl Parahydroxybenzoate
0.2 mg
For the full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Oral suspension
A smooth uniform off-white to yellow suspension
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
INDICATIONS:
Treatment of chronic fascioliasis caused by the adult stage of _Fasciola hepatica_, sensitive to oxyclozanide.
Elimination of gravid tapeworm segments (_Moniezia _spp).
4.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 09/09/2016_
_CRN 7024383_
_page number: 1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
At normal dose levels, oxyclozanide is not active against immature flukes present in liver tissue.
Milking cattle, particularly high yielders, may show a reduction in yield, occasionally of 5 % or more, for about 48
hours after handling. The effect of this small loss may be minimised by spreading herd dosing over a period of about
one week.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 09/09/2016_
_CRN 7024383_
_page number: 2_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
When a dosing gun is used to administer the product, care must be taken to avoid damage to the pharyngeal region.
Adverse effects 
                                
                                Soma hati kamili
                                
                            

Tafuta arifu zinazohusiana na bidhaa hii